Caroline Pearson testified before the United States Senate Committee on Finance on the importance of improved healthcare data transparency.
Her testimony summarized key findings from the Center’s work and other research on how transparency can shape healthcare markets. It also puts forth a range of policy options that Congress and the Executive Branch should consider to further advance discrete elements of healthcare data transparency, with an emphasis on how to improve the depth, breadth and usability of pricing data.
United States Senate Committee on Finance
Making Sense of CMS’s New Approach to Technology and Payment
Executive Director Caroline Pearson examines what CMS’s 2027 Medicare Physician Fee Schedule signals for technology innovators and healthcare leaders.
CMS’s ACCESS Model in Context: Outcome-Based Payment for Health Technologies
The Center examines how evaluations of health technologies laid the groundwork for broader outcome-based payment models, such as ACCESS.
Center Responds to Department of Labor Proposed Rule on Third-Party Vendor Fee Disclosure
The Center offers recommendations to expand PBM fee disclosure requirements to all third-party administrators and improve employer access to claims data.